反应详情

A solution of 2-bromo-1-(2-methyl-3-((2,2,2-trifluoroethyl)amino)quinoxalin-5-yl)ethanone (616) (40 mg, 0.11 mmol), piperidine-2,4-dione (Inogent, Hyderabad, India) (24.99 mg, 0.22 mmol), and NH4OAc (42.6 mg, 0.55 mmol) in EtOH (1.1 mL) was stirred at 40° C. for 2.5 d. The crude product was adsorbed onto silica and was purified via automated flash chromatography (silica gel) with 100% DCM to 4% 2 M NH3 in MeOH/DCM to give impure product. The crude product was dissolved in DMSO (˜20 mg/mL) and injected (1×1.0 mL) onto the Shimadzu preparatory LC (Phenomenex Gemini C18, 10 μm, 150×30 mm; 10-100% MeCN/water with 0.1% TFA); the pure fraction was concentrated via rotary evaporation to give 2-(2-methyl-3-((2,2,2-trifluoroethyl)amino)quinoxalin-5-yl)-6,7-dihydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-one (336) (4 mg, 6% yield) as a brick red solid. 1H NMR (400 MHz, MeOH) δ ppm 2.66 (s, 3H) 2.99 (t, J=7.04 Hz, 2H) 3.65 (t, J=7.24 Hz, 2H) 4.38 (q, J=9.52 Hz, 2H) 7.09 (s, 1H) 7.48 (t, J=7.82 Hz, 1H) 7.70 (d, J=8.02 Hz, 1H) 7.98 (d, J=7.24 Hz, 1H) 11.98 (br. s., 1H). 19F NMR (377 MHz, MeOH) δ ppm −77.59 (br. s., 6F) −72.18 (s, 3F). MS (ESI, pos. ion) m/z: 376.1 (M+1).

1. customwas purified
2. customto give impure product
3. concentrationthe pure fraction was concentrated via rotary evaporation